These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 25109303)
1. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1. Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303 [TBL] [Abstract][Full Text] [Related]
2. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells. Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499 [TBL] [Abstract][Full Text] [Related]
3. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Guo S; Xu X; Tang Y; Zhang C; Li J; Ouyang Y; Ju J; Bie P; Wang H Cancer Lett; 2014 Mar; 344(1):40-46. PubMed ID: 24252251 [TBL] [Abstract][Full Text] [Related]
4. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. Zhu Z; Xu Y; Du J; Tan J; Jiao H J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3. Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446 [TBL] [Abstract][Full Text] [Related]
6. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830 [TBL] [Abstract][Full Text] [Related]
7. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191 [TBL] [Abstract][Full Text] [Related]
8. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I. Song B; Ji W; Guo S; Liu A; Jing W; Shao C; Li G; Jin G FEBS Lett; 2014 Nov; 588(23):4375-81. PubMed ID: 25315416 [TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma. Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060 [TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin. Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients. Sun B; Liu X; Gao Y; Li L; Dong Z Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Dang Z; Xu WH; Lu P; Wu N; Liu J; Ruan B; Zhou L; Song WJ; Dou KF Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381 [TBL] [Abstract][Full Text] [Related]
14. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival. He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783 [TBL] [Abstract][Full Text] [Related]
15. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells. Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897 [TBL] [Abstract][Full Text] [Related]
17. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b. Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells. Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161 [TBL] [Abstract][Full Text] [Related]
19. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Wang C; Sun Y; Wu H; Yu S; Zhang L; Meng Y; Liu M; Yang H; Liu P; Mao X; Lu Z; Chen J Tumour Biol; 2015 Dec; 36(12):9447-56. PubMed ID: 26124009 [TBL] [Abstract][Full Text] [Related]
20. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma. Wu Z; Zhou L; Ding G; Cao L Cancer Biomark; 2017; 18(1):35-39. PubMed ID: 27814273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]